ACCURATE Trial - Operative Treatment of Acute Rotator Cuff Tear Related to Trauma

April 28, 2025 updated by: Turku University Hospital

ACCURATE Trial - Operative Treatment of Acute Rotator Cuff Tear Related to Trauma; a Placebo-controlled Efficacy Trial

Rotator cuff tear is a very common and disabling condition that can be related to acute trauma such as falling on the shoulder. A tear is associated with symptoms such as pain in abduction, abduction weakness and night pain. Rotator cuff tear surgery is a well-established form of treatment in acute rotator cuff tears, although beneficial results have been reported for both conservative and surgical treatment of rotator cuff tears. Rotator cuff tear repair surgery involves a considerable amount of re-ruptures, and it is possible that the repaired tendon do not heal despite surgical repair. On the other hand rotator cuff tears are also found in completely asymptomatic persons and the clinical significance of a rupture may be generally lower than estimated. The above-mentioned factors, as well as recent research and meta-analysis on the treatment of mainly degenerative rotator cuff tears indicate that there is a limited evidence that surgery is not more effective in treating symptomatic rotator cuff tear than conservative treatment alone. However, these previous research findings cannot be applied directly to traumatic tears, although degeneration can be considered always to contribute to the creation of a rotator cuff tear.

During few last decades, despite the lack of evidence on the superiority of one treatment over another, the use of surgery to treat this disorder has been substantially increased. Treatment expectations are found to be important in predicting patient related outcome measures. In addition, surgery itself may produce a profound placebo effect. There are no previous placebo-controlled trials on the topic of interest. In order to find out the true efficacy of surgical treatment of acute, trauma related rotator cuff tears involving mainly the supraspinatus tendon, the investigators have designed this multi-centre, randomized, placebo-controlled efficacy trial.

Study Overview

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Helsinki, Finland
        • Helsinki University Hospital
      • Jyväskylä, Finland
        • Central Finland Central Hospital
      • Kuopio, Finland
        • Kuopio University Hospital
      • Oulu, Finland
        • Oulu University Hospital
      • Pori, Finland
        • Satakunta Central Hospital
      • Tampere, Finland
        • Tampere University Hospital
      • Tampere, Finland
        • Hatanpää Hospital
      • Turku, Finland
        • Turku University Hospital
      • Vaasa, Finland
        • Vaasa Central Hospital
      • Arendal, Norway
        • Sørlandet Sykehus HF
      • Oslo, Norway
        • Oslo University Hospital, Ullevål hospital
      • Sandvika, Norway
        • Martina Hansens Hospital
      • Trondheim, Norway
        • St. Olafs Hospital HF
      • Helsingborg, Sweden
        • Skånevård Sund, Region Skåne
      • Kalmar, Sweden
        • Kalmar County Hospital
      • Linköping, Sweden
        • Linkoping University Hospital
      • Varberg, Sweden
        • Varberg Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age of patient over 45 and below 70 years
  2. Acute onset of shoulder symptoms after a traumatic event (any kind of sudden stretch, pull, fall, or impact, on the shoulder that is associated with the onset of symptoms)
  3. Shoulder symptoms relating to rotator cuff tear = pain laterally on the shoulder and/or painful motion arc during abduction or flexion
  4. MRI documented full thickness supraspinatus (ssp) tear

Exclusion Criteria:

  1. Traumatic event of the shoulder due a criminal act of violence with legal consequences
  2. A delay of more than 4 months after the onset of symptoms of trauma to the day of intervention
  3. Arthroscopically documented partial thickness rotator cuff tear only
  4. A large MRI documented full thickness rotator cuff tear, sagittal tear size at the level of footprint larger than 3cm
  5. MRI or arthroscopically documented total width of infraspinatus (isp) or subscapularis (ssc) tear
  6. MRI or arthroscopically documented fully dislocated biceps tendon (biceps out of the groove) with concomitant subscapularis tear
  7. Positive clinical rotatory lag sign (ER1 lag (>10 degrees), lift off lag (involuntary drop against the back), horn blower lag (involuntary internal rotation of the forearm in supported elevated position))
  8. Marked fatty degeneration in any of the cuff muscles (more than Fuchs/Goutallier grade 2)
  9. Radiographically or MRI documented concomitant fracture line of the involved extremity or bony avulsion of the torn tendon or dislocation of the humeral head or the acromioclavicular joint.
  10. Concomitant clinically detectable motoric nerve injury affecting the shoulder
  11. Radiographically documented severe osteoarthritis of the glenohumeral joint, Samilson-Prieto 2 or above
  12. Non-congruency of the glenohumeral joint in radiographs (Hamada stage 2 or above)
  13. Clinical stiffness of the glenohumeral joint (severely limited passive range of motion: glenohumeral external rotation < 30 degrees, and abduction with stabilized scapula <60 degrees)
  14. Previous surgery of the affected shoulder (affecting clavicle, scapula or upper third of the humerus)
  15. Earlier sonographic or MRI finding of a rotator cuff tear
  16. Previous symptoms of the ipsilateral shoulder requiring conservative treatment (glucocorticosteroid injections and/or physiotherapy) delivered by health care professionals during the last five years
  17. Systemic glucocorticosteroid or antimetabolite medication during the last 5 years
  18. Ongoing treatment for malignancy
  19. ASA classification 3 or 4
  20. Patient's inability to understand written and spoken Finnish, Norwegian or Swedish
  21. History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardise informed consent
  22. Patients with a contraindication/noncomplience for MRI examination or use of electrocautery devices
  23. Previous randomization of the contralateral shoulder into the ACCURATE trial
  24. Patient's denial for operative treatment and/or participation in the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Group I
Placebo surgery + supervised specific exercises
The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated. Nothing is to be removed or excised and the use of any vapour or shaver device is not allowed. The presence of a full-thickness rotator cuff tear is verified. Altogether 3 to 5 small stab wounds are made in typical locations resembling locations of typical rotator cuff repair. The time spent in the operating theatre with patients in placebo group should resemble the time spent with patients in the active treatment group and hence give an impression of a rotator cuff repair.
Active Comparator: Group II
Rotator cuff repair + supervised specific exercises
The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated and the presence of a full-thickness rotator cuff tear is verified. The cuff tear is repaired to its anatomic location using suture anchors according to surgeon preference. . A biceps tenotomy or tenodesis may be performed according to surgeon preference if the biceps tendon is noted to be frayed, unstable or inflamed. An additional acromioplasty may be performed according to surgeon preference.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Western Ontario Rotator Cuff index (WORC) compared to baseline at two years.
Time Frame: The change of WORC is also compared to baseline at 3 and 6 months, 1 , 2, 5 and 10 years
Patient reported disease specific outcome measure for rotator cuff conditions.
The change of WORC is also compared to baseline at 3 and 6 months, 1 , 2, 5 and 10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Constant Score
Time Frame: 3 and 6 months, 1 , 2, 5 and 10 years
Shoulder specific outcome measure combining subjective and objective variables
3 and 6 months, 1 , 2, 5 and 10 years
Numeric rating scale of patients' shoulder pain during the last week at rest, during activity and at night.
Time Frame: 3 and 6 months, 1 , 2, 5 and 10 years
Subjective pain intensity measure. The numeric pain rating scale (pain NRS). Scale 0 to 10. 0 = no pain and 10 = worst possible pain.
3 and 6 months, 1 , 2, 5 and 10 years
15D
Time Frame: 3 and 6 months, 1 , 2, 5 and 10 years
Generic health-related quality of life instrument
3 and 6 months, 1 , 2, 5 and 10 years
Subjective patient satisfaction
Time Frame: 3 and 6 months, 1 , 2, 5 and 10 years
Patient reported scale for treatment satisfaction
3 and 6 months, 1 , 2, 5 and 10 years
Rotator cuff integrity in MRI investigation
Time Frame: 2, 5 and 10 years
2, 5 and 10 years
Development of osteoarthritic signs in radiographs
Time Frame: 2, 5 and 10 years
2, 5 and 10 years
Development of cuff tear arthropathy in radiographs
Time Frame: 2, 5 and 10 years
2, 5 and 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Juha Kukkonen, MD, PhD, Satakunta Central Hospital
  • Study Chair: Anssi Ryösä, MD, Turku University Hospital
  • Study Chair: Hanna Björnsson Hallgren, MD, PhD, University Hospital, Linkoeping
  • Study Chair: Stefan Moosmayer, MD, PhD, Martina Hansens Hospital
  • Study Chair: Teresa Holmgren, PT, PhD, University Hospital, Linkoeping
  • Study Chair: Mats Ranebo, MD, Kalmar County Hospital
  • Study Chair: Berte Bøe, MD, PhD, Oslo University Hospital
  • Study Director: Ville Äärimaa, Adj.Prof., Turku University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (Actual)

January 1, 2025

Study Completion (Actual)

January 1, 2025

Study Registration Dates

First Submitted

August 19, 2016

First Submitted That Met QC Criteria

August 26, 2016

First Posted (Estimated)

August 31, 2016

Study Record Updates

Last Update Posted (Actual)

May 1, 2025

Last Update Submitted That Met QC Criteria

April 28, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • ACCURATE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Rotator Cuff Tear Related to Trauma

Clinical Trials on Placebo surgery and supervised specific exercises

Subscribe